Circulating cell-free DNA in sickle cell disease: Is it a potentially useful biomarker?

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 5, 2014, Pages 678-683

  Al Humood, Salah ^a   Zueriq, Rajaa ^a   Al Faris, Lama ^a   Marouf, Rajaa ^a   Al Mulla, Fahd ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; HEMOGLOBIN S; TELOMERASE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; SICKLE CELL ANEMIA; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-GLOBINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA; FEMALE; FETAL HEMOGLOBIN; HEMOGLOBIN, SICKLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TELOMERASE; YOUNG ADULT;

EID: 84900506324     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0725-OA     Document Type: Article

References (25)

1. Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994
2. Serjeant GR, Serjeant BE. Sickle Cell Disease. Oxford, United Kingdom: Oxford University Press; 2001
3. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med. 1991;325(1):11-16
4. Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002;9(2):101-106 (Pubitemid 34171484)
5. Mandel P, Metais P. Les acides nucleiques du plasma sanguin chez l'homme. C R Seances Soc Biol Fil. 1948;142(3-4):241-243
6. Leon SA, Green A, Yaros MJ, Shapiro B. Radioimmunoassay for nanogram quantities of DNA. J Immunol Methods. 1975;9(2):157-164
7. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(3):646-650 (Pubitemid 8051621)
8. Vasavda N, Ulug P, Kondaveeti S, et al. Circulating DNA: a potential marker of sickle cell crisis. Br J Haematol. 2007;139(2):331-336 (Pubitemid 47493082)
9. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology. 2007;39(2):197-207 (Pubitemid 46439650)
10. Shapiro B, Chakrabarty M, Cohn EM, Leon SA. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer. 1983;51(11):2116-2120 (Pubitemid 13092467)
11. Steinman CR. Circulating DNA in systemic lupus erythematosus: isolation and characterization. Am J Med. 1979;67(3):429-435
12. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000;46(3):319-323 (Pubitemid 30152256)
13. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000; 106(3):411-420 (Pubitemid 30655641)
14. Serjeant GR, Ceulaer, CD, Lethbridge R, Morris J, Singhal A, Thomas PW. The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol. 1994;87(3):586-591 (Pubitemid 24230027)
15. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62(4):768-775 (Pubitemid 28194317)
16. Zhang J, Tong KL, Li PK, et al. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin Chem. 1999;45(10):1741-1746 (Pubitemid 29477330)
17. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485-487 (Pubitemid 27343304)
18. Fournie GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death: investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 1995;91(2):221-227
19. Sozzi G, Conte D, Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003;21(21):3902-3908 (Pubitemid 46606202)
20. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635(2-3):105-117 (Pubitemid 46756399)
21. Botezatu I, Serdyuk O, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem. 2000;46(8, pt 1):1078- 1084 (Pubitemid 30643308)
22. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (Hb S) allele and sickle cell disease: a HuGE review. Am J Epidemiol. 2000;151(9):839-845 (Pubitemid 30461125)
23. Gerovassili A, Nicolaides KH, Thein SL, Rees DC. Cell-free DNA levels in pregnancies at risk of sickle cell disease and significant ethnic variation. Br J Haematol. 2006;135(5):738-741 (Pubitemid 44674088)
24. Smith WR, Coyne P, Smith VS, Mercier B. Temperature changes, temperature extremes, and their relationship to emergency department visits and hospitalizations for sickle cell crisis. Pain Manag Nurs. 2003;4(3):106-111 (Pubitemid 37336916)
25. Devine DV, Kinney TR, Thomas PF, Rosse WF, Greenberg CS. Fragment Ddimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood. 1986;68(1):317-319. (Pubitemid 16033652)